Kotak Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 18.847 ↑ 0.43%
[as on 13 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of Kotak Healthcare Fund - Direct Plan - Growth Option and its peers as on 13 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Kotak Healthcare Fund - Direct Plan - Growth Option 37.07% 0.43% 4.28% 9.68% 8.5% 34.24%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.29% -0.27% 0.2% 3.18% -6.26% -10.5% 4.93% 8.92% 13.82% 14.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth 0.75% -0.5% 1.2% 9.63% 2.07% 1.58% 11.19% 7.88% 12.9% 12.67%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 29.68% -0.01% 3.26% 10.03% 4.42% 26.07% 25.42% 20.65% 26.17% 15.92%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.39% -0.04% 1.28% 6.76% -0.65% 3.49% 12.47% 14.96% 19.21% 15.81%
SBI COMMA Fund - DIRECT PLAN - Growth 4.37% -0.55% 0.42% 4.29% -2.46% 6.57% 14.27% 9.88% 18.09% 14.96%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 42.3% -5.91%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -4.55% 7.53% -4.14% 7.75% 5.51% 7.75% 3.89% 3.63% -0.49% -0.53%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.45%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.66% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.34%

Equity

NameSymbol / ISINSectorWeight %Other links
SUN PHARMACEUTICAL INDUSTRIES LTD.SUNPHARMA (INE044A01036)Pharmaceuticals and Biotechnology13.96%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals and Biotechnology9.25%
TORRENT PHARMACEUTICALS LTD.TORNTPHARM (INE685A01028)Pharmaceuticals and Biotechnology4.75%
MOLBIO DIAGNOSTICS LIMITED (INE869T01028)Healthcare Services4.53%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services4.34%
Ami Organics LtdACUTAAS (INE00FF01025)Pharmaceuticals and Biotechnology3.91%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals and Biotechnology3.67%
PARK MEDI WORLD LIMITED (PARK HOSPITAL)PARKHOSPS (INE119201023)Healthcare Services3.36%
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTDYATHARTH (INE0JO301016)Healthcare Services3.25%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services3.25%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals and Biotechnology3.04%
SAI LIFE SCIENCES LIMITEDSAILIFE (INE570L01029)Pharmaceuticals and Biotechnology3.04%
Fortis Healthcare India LtdFORTIS (INE061F01013)Healthcare Services2.95%
MANKIND PHARMA LTDMANKIND (INE634S01028)Pharmaceuticals and Biotechnology2.84%
Marksans Pharma LtdMARKSANS (INE750C01026)Pharmaceuticals and Biotechnology2.51%
Laurus Labs LtdLAURUSLABS (INE947Q01028)Pharmaceuticals and Biotechnology2.49%
KRISHNA INSTITUTE OF MEDICALKIMS (INE967H01025)Healthcare Services2.46%
RUBICON RESEARCH LIMITEDRUBICON (INE506V01022)Pharmaceuticals and Biotechnology2.37%
ANTHEM BIOSCIENCES LTDANTHEM (INE0CZ201020)Pharmaceuticals and Biotechnology2.33%
Ajanta Pharma Ltd.AJANTPHARM (INE031B01049)Pharmaceuticals and Biotechnology2.11%
VIYASH SCIENTIFIC LTDVIYASH (INE807F01027)Pharmaceuticals and Biotechnology2.01%
ORCHID PHARMA LIMITEDORCHPHARMA (INE191A01027)Pharmaceuticals and Biotechnology1.64%
CORONA REMEDIES LIMITEDCORONA (INE02ZQ01018)Pharmaceuticals and Biotechnology1.60%
EMCURE PHARMACEUTICALS LIMITEDEMCURE (INE168P01015)Pharmaceuticals and Biotechnology1.57%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals and Biotechnology1.57%
JUBILANT INGREVIA LTD.JUBLINGREA (INE0BY001018)Chemicals and Petrochemicals1.49%
RAINBOW CHILDRENS MEDICARE LTDRAINBOW (INE961O01016)Healthcare Services1.29%
Pfizer Ltd.PFIZER (INE182A01018)Pharmaceuticals and Biotechnology1.16%
JUBILANT PHARMOVA LIMITEDJUBLPHARMA (INE700A01033)Pharmaceuticals and Biotechnology1.15%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals and Biotechnology1.14%
METROPOLIS HEALTHCARE LTD.METROPOLIS (INE112L01020)Healthcare Services1.14%
Zydus Lifesciences Ltd.ZYDUSLIFE (INE010B01027)Pharmaceuticals and Biotechnology1.13%
DR.Lal Pathlabs LtdLALPATHLAB (INE600L01024)Healthcare Services1.11%
INNOVA CAPTABS LTDINNOVACAP (INE0DUT01020)Pharmaceuticals and Biotechnology1.08%
LAXMI DENTAL LIMITEDLAXMIDENTL (INE0WO601020)Healthcare Equipment and Supplies0.17%
Portfolio data is as on date 31 August, 2026

NAV history

Kotak Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
13 November, 202618.847 0.43%
12 November, 202618.766 0.66%
11 November, 202618.643 -0.02%
9 November, 202618.646 3.17%
6 November, 202618.073 0.09%
5 November, 202618.057 1.31%
4 November, 202617.824 1.05%
3 November, 202617.639 0.74%
2 November, 202617.51 0.38%
30 October, 202617.444 0.6%
29 October, 202617.34 0.85%
28 October, 202617.194 0.91%
27 October, 202617.039 2.64%
26 October, 202616.6 1.62%
23 October, 202616.336 -0.92%
22 October, 202616.487 -0.21%
21 October, 202616.521 -1.3%
19 October, 202616.739 -1.5%
16 October, 202616.994 0.48%
15 October, 202616.913 -0.52%
14 October, 202617.001 -1.06%
13 October, 202617.184 -0.37%
12 October, 202617.247 -0.25%
9 October, 202617.291 0.41%
8 October, 202617.221 -2.64%
7 October, 202617.688 0.31%
6 October, 202617.633 1.34%
5 October, 202617.399 -1.16%
1 October, 202617.604 0.29%
30 September, 202617.553

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is 18.847 as on 13 November, 2026.
  • What are YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 37.07% as on 13 November, 2026.
  • What are 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 34.24% as on 13 November, 2026.
  • What are top 10 holdings of Kotak Healthcare Fund - Direct Plan - Growth Option?
    Top 10 holdings of Kotak Healthcare Fund - Direct Plan - Growth Option are:
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
    • Divis Laboratories Ltd.
    • TORRENT PHARMACEUTICALS LTD.
    • MOLBIO DIAGNOSTICS LIMITED
    • Max Healthcare Institute Ltd.
    • Ami Organics Ltd
    • Cipla Ltd.
    • PARK MEDI WORLD LIMITED (PARK HOSPITAL)
    • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD
    • Apollo Hospitals Enterprise Ltd.
    • Gland Pharma Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Kotak Healthcare Fund - Direct Plan - Growth Option?
    Kotak Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.